We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISDMR:BISTIskenderun Demir ve Celik AS Analysis

Data as of 2026-03-15 - not real-time

TRY 41.70

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Iskenderun Demir ve Çelik A.S. is trading at ~41.7 TRY, comfortably above the computed support of 39.78 TRY but well below the 52‑week high of 48.22 TRY, suggesting room for upside. Technical indicators show a bullish trend with the 20‑day SMA (43.37) above the 50‑day (41.57) and 200‑day (38.13) averages, while the RSI sits at a neutral 45 and the MACD is currently bearish, hinting at short‑term consolidation. Fundamentally, the stock appears markedly undervalued: a price‑to‑book of 0.82 and a forward DCF fair value of 121.3 TRY imply a large upside potential, while the trailing P/E of ~20 is modest for the steel sector. The company generates solid cash (≈50.7 B TRY) against manageable debt (≈39.7 B TRY), yielding a net‑cash position and a low payout ratio of ~12%, supporting dividend sustainability. However, margins are thin (gross 9%, operating 8%) and revenue growth modest at 4.2%, reflecting the cyclical nature of the steel industry. The stock’s beta of 0.21 and a 30‑day volatility of ~36% signal low market sensitivity but high price swings, especially given Turkey’s macro‑economic environment. Overall, the blend of strong balance‑sheet metrics, low valuation multiples, and technical bullishness supports a positive outlook, though short‑term price pressure near support and bearish MACD suggest caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above key support level
  • Bearish MACD histogram indicating possible downside pressure
  • Decreasing volume trend reducing short‑term momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Bullish SMA alignment confirming upward trend
  • Significant valuation gap (DCF fair value > price)
  • Strong cash position and low leverage supporting stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Long‑term upside implied by low price‑to‑book and high DCF valuation
  • Low beta indicating limited market volatility over extended horizon

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin5.05%
P/E Ratio19.8
ROE4.63%
ROA2.08%
Debt/Equity26.93
P/B Ratio0.8
Op. Cash FlowTRY37.0B
Free Cash FlowTRY20.9B

Technical Analysis

TrendBullish
RSI45.4
SupportTRY 39.78
ResistanceTRY 48.22
MA 20TRY 43.37
MA 50TRY 41.57
MA 200TRY 38.13
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueTRY 121.32
GradeUndervalued
TypeValue
Dividend Yield0.60%

Risk Assessment

Beta0.29
Volatility35.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.